Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, et al. N Engl J Med 2021 Sep 29. doi: 10.1056/NEJMoa2105290.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Falsey AR, Sobieszczyk ME, Hirsch I, Sproule S, et al. Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine. N Engl J Med 2021 Sep 29. doi: 10.1056/NEJMoa2105290.
PMID: 34587382